Electromed, Inc. Schedules Its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 P.m. ET
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its
Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief
NYSE American New 52-Week Highs And Lows
New Highs 12 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ AEON Biopharma Wt AEON.WS 2.20 262,729 A
Electromed(ELMD.US) Officer Buys US$137.25K in Common Stocks
$Electromed(ELMD.US)$ Officer Cunniff James L. purchased 9,000 shares of Common Stocks on Mar 1, 2024 at an average price of $15.25 for a total value of $137.25K.Source: Announcement What is statement
Electromed, Inc. to Participate in the 2024 Sidoti March Small-Cap Virtual Conference
Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersCogent Biosciences (NASDAQ:COGT) stock increased by 64.0% to $8.96 during Wednesday's regular session. The company's market cap stands at $771.2 million. Larimar Therapeutics (NASDAQ:LRMR) shar
Earnings Call: Electromed Posts Record Revenue and Earnings in Q2
Analysts' Top Healthcare Picks: Electromed (ELMD), Codexis (CDXS)
Electromed, Inc. (AMEX:ELMD) Q2 2024 Earnings Call Transcript
Earnings Call Summary | Electromed(ELMD.US) Q2 2024 Earnings Conference
The following is a summary of the Electromed, Inc. (ELMD) Q2 2024 Earnings Call Transcript:Financial Performance:Electromed's Q2 net revenue increased by 17% over the last year, reaching a record of $
Electromed Updates Investor Presentation for Transparency
Electromed Q2 Gaap EPS $0.19 Beats $0.10 Estimate, Sales $13.69M Beat $13.30M Estimate
Electromed (AMEX:ELMD) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.10 by 90 percent. This is a 72.73 percent increase over earnings of $0.11 per shar
Press Release: Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter
Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter Growth initiatives drive record revenue, improve margins and enhance operational efficiency NEW PRAGUE, Minn.--(
Electromed 2Q EPS 19c >ELMD
Electromed 2Q EPS 19c >ELMD
Earnings Scheduled For February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. • Navios Maritime Partners (NYSE:NMM) is projected
Earnings Outlook For Electromed
Electromed (AMEX:ELMD) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here's what investors need to know before the announcement.Analysts estimate that Electromed will rep
Electromed, Inc. Schedules Its Second Quarter Fiscal 2024 Financial Results Conference Call for February 13, 2024 at 5:00 P.m. ET
Electromed Entered Into Distribution Agreement With Marathon Medical Corp; Financial Terms Not Disclosed
Electromed Entered Into Distribution Agreement With Marathon Medical Corp; Financial Terms Not Disclosed
Electromed, Inc. Announces Partnership to Expand SmartVest Access to Veterans, Federal Employees, and Native American Communities
Electromed, Inc. (NYSE:ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB).
Electromed, Inc. to Participate in the Virtual 2024 Lytham Partners Investor Select Conference
Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief
No Data